The rise in the incidence of cardiovascular conditions in developing countries is ascribed to the shift in lifestyles and adoption of modernized facilities, leading to an increase in the prevalence of other health conditions associated with cardiovascular disease. The modernization of residential, commercial, and corporate facilities has lowered the need for physical activities among people; in contrast, stress levels among people are rising due to various personal and social factors, which are driving the prevalence of cardiovascular disease in developing countries. Moreover, these countries are bringing significant developments in healthcare facilities and services based on technological advancements. The Asia Pacific cardiovascular devices market is expected to grow at a good CAGR during the forecast period.
Asia Pacific Cardiovascular Devices Market Segmentation
The Asia Pacific cardiovascular devices market is segmented into device, application, end user, and country. Based on device, the market is segmented into electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor, and others. The event monitor segment dominated the market in 2020. In terms of application, the Asia Pacific cardiovascular devices market is segmented into coronary heart disease, sudden cardiac arrest, stroke, cerebrovascular heart disease, and others. The coronary heart disease segment dominated the market in 2020. Based on end-user, the Asia Pacific cardiovascular devices market is segmented into hospitals, ambulatory surgery centers, and cardiac centers. The hospitals segment dominated the Asia Pacific cardiovascular devices market in 2020. In terms of country, the Asia Pacific cardiovascular devices market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Japan dominated the Asia Pacific cardiovascular devices market in 2020.
Medtronic, Boston Scientific Corporation, Abbott, Johnson and Johnson Service Inc, General Electric Company, Koninklijke Philips N.V, Siemens Healthineers AG, BD, B. Braun Melsungen AG, and Edwards Lifesciences Corporation are among the leading companies in the Asia Pacific cardiovascular devices market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 8,991.10 Million |
| Market Size by 2028 | US$ 14,846.18 Million |
| CAGR (2021 - 2028) | 7.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Device
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Cardiovascular Devices Market is valued at US$ 8,991.10 Million in 2021, it is projected to reach US$ 14,846.18 Million by 2028.
As per our report Asia Pacific Cardiovascular Devices Market, the market size is valued at US$ 8,991.10 Million in 2021, projecting it to reach US$ 14,846.18 Million by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.
The Asia Pacific Cardiovascular Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Cardiovascular Devices Market report:
The Asia Pacific Cardiovascular Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Cardiovascular Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Cardiovascular Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Cardiovascular Devices Market
